rescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- He said he was leaving. She ignored him.
- How my boyfriend and I learned to live on one income
- 31 TV shows to watch in 2014
- Why the poor's investment of choice is so alarming
- Affirmative action is doomed. Here's what progressives should do about it.
- Why China's Communist Party is headed for collapse
- What would a U.S.-Russia war look like?
- Obama's next steps on immigration
- How to make perfect fried rice in 6 easy steps
- Why Texas Republicans may want to cool the anti-Obama land-grab talk
Subscribe to the Week